{"disease":{"id":"superoxide-dismutase","name":"superoxide dismutase"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06430008","title":"The Relationship Between Total Sialic Acid and Superoxide Dismutase and the Diagnosis and Prognosis of Lipoid Pneumonia","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":160,"lead_sponsor_name":"Hu Yinan","has_results":false},{"nct_id":"NCT03070119","title":"Long-Term Evaluation of BIIB067 (Tofersen)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":139,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT06351592","title":"First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT04919850","title":"Effect of 60-days Saccharomyces Boulardii and Superoxide Dismutase Supplementation in Obese Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Azienda di Servizi alla Persona di Pavia","has_results":false},{"nct_id":"NCT04972487","title":"Expanded Access Program for Tofersen in Participants With Superoxide Dismutase 1-Amyotropic Lateral Sclerosis","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Biogen","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}